We are live on
!
Find out more
3C
361 Capital Portfolio holdings
AUM
$213M
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
+35.34%
1 Year Est. Return
+24.26%
3 Year Est. Return
+117.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$213M
AUM Growth
-$6.7M
(-3%)
Cap. Flow
-$47.5M
Cap. Flow
% of AUM
-22.27%
Top 10 Holdings %
Top 10 Hldgs %
8.05%
Holding
403
New
118
Increased
30
Reduced
151
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lear
LEA
|
+$1.16M |
| 2 |
Americold
COLD
|
+$1.09M |
| 3 |
Republic Services
RSG
|
+$1.07M |
| 4 |
Howmet Aerospace
HWM
|
+$1.07M |
| 5 |
Intercontinental Exchange
ICE
|
+$911K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chemed
CHE
|
+$1.96M |
| 2 |
Helen of Troy
HELE
|
+$1.64M |
| 3 |
FTI Consulting
FCN
|
+$1.55M |
| 4 |
Spire
SR
|
+$1.54M |
| 5 |
McKesson
MCK
|
+$1.54M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.4% |
| 2 | Healthcare | 16.28% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISBC
201
DELISTED
Investors Bancorp, Inc.
ISBC
| $588K | 0.28% |
69,120
-10,722
| -13% | -$90.2K |
|
202
Target
TGT
$63.5B
| $587K | 0.28% |
4,891
-115
| -2% | -$13.1K |
|
|
GBT
203
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $582K | 0.27% |
+9,222
| New | +$633K |
|
204
Performance Food Group
PFGC
$17.9B
| $581K | 0.27% |
19,923
-3,091
| -13% | -$80.4K |
|
205
Amgen
AMGN
$203B
| $574K | 0.27% |
+2,434
| New | +$555K |
|
|
PFC
206
DELISTED
Premier Financial Corp. Common Stock
PFC
| $574K | 0.27% |
32,470
-5,044
| -13% | -$81.6K |
|
|
LMNX
207
DELISTED
Luminex Corp
LMNX
| $573K | 0.27% |
+17,617
| New | +$557K |
|
208
Dover
DOV
$27.5B
| $571K | 0.27% |
5,911
-1,884
| -24% | -$174K |
|
209
Group 1 Automotive
GPI
$4.02B
| $569K | 0.27% |
8,624
-1,337
| -13% | -$76.5K |
|
210
OSI Systems
OSIS
$3.53B
| $565K | 0.26% |
7,564
-1,174
| -13% | -$85.8K |
|
211
Zebra Technologies
ZBRA
$12.6B
| $558K | 0.26% |
2,182
-51
| -2% | -$12K |
|
212
Targa Resources
TRGP
$58.2B
| $553K | 0.26% |
+27,541
| New | +$414K |
|
213
Huntington Ingalls Industries
HII
$11.3B
| $552K | 0.26% |
3,163
-3,988
| -56% | -$741K |
|
214
Invesco Global ex-US High Yield Corporate Bond ETF
PGHY
$222M
| $552K | 0.26% |
25,941
+94
| +0.4% | +$1.95K |
|
215
Primerica
PRI
$9.83B
| $541K | 0.25% |
4,636
-3,175
| -41% | -$338K |
|
|
DSSI
216
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $539K | 0.25% |
+67,504
| New | +$713K |
|
217
Adobe
ADBE
$96B
| $538K | 0.25% |
1,236
-474
| -28% | -$176K |
|
218
Intel
INTC
$454B
| $529K | 0.25% |
8,834
-2,573
| -23% | -$154K |
|
219
BWX Technologies
BWXT
$16B
| $523K | 0.25% |
9,239
-6,446
| -41% | -$360K |
|
220
ConocoPhillips
COP
$142B
| $522K | 0.24% |
+12,423
| New | +$502K |
|
221
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.48B
| $512K | 0.24% |
6,128
+490
| +9% | +$39.2K |
|
222
ScottsMiracle-Gro
SMG
$4.03B
| $509K | 0.24% |
3,786
-5,156
| -58% | -$666K |
|
223
Lam Research
LRCX
$356B
| $504K | 0.24% |
15,580
-4,000
| -20% | -$109K |
|
224
Aecom
ACM
$9.16B
| $499K | 0.23% |
+13,278
| New | +$476K |
|
|
SEM
225
DELISTED
Select Medical
SEM
| $484K | 0.23% |
61,040
-9,479
| -13% | -$78.5K |
|
Similar funds
SIA
PV
RCM
ALIA
TL
RI
SMFS
HF
361 Capital's Q2 2020 Portfolio in Review
As of Q2 2020, 361 Capital held 403 positions worth $213M, down 3% from $220M the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
361 Capital withdrew a net $47.5M in Q2 2020, closing 104 positions and reducing 151 holdings. Its most notable exit was Chemed, an estimated $1.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, 361 Capital opened a new position in Lear worth $1.27M.
- 361 Capital's largest Q2 2020 buy was Lear: 11,650 shares worth $1.27M.
- 361 Capital added most to DaVita in Q2 2020, an estimated $427K increase.
- 361 Capital's biggest Q2 2020 reduction was Williams Companies, cutting an estimated $1.41M.
- 361 Capital fully exited Chemed in Q2 2020, selling an estimated $1.96M.
- 361 Capital's ten largest holdings make up 8.1% of its $213M portfolio in Q2 2020.
- 361 Capital opened 118 new positions and closed 104 in Q2 2020.
- 361 Capital's portfolio value fell 3% quarter-over-quarter to $213M.
Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.